DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 64 filers reported holding DERMA SCIENCES INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $18,000 | +12.5% | 3,494 | 0.0% | 0.00% | – |
Q3 2016 | $16,000 | +14.3% | 3,494 | 0.0% | 0.00% | – |
Q2 2016 | $14,000 | +16.7% | 3,494 | -10.0% | 0.00% | – |
Q1 2016 | $12,000 | -33.3% | 3,882 | 0.0% | 0.00% | – |
Q4 2015 | $18,000 | 0.0% | 3,882 | 0.0% | 0.00% | – |
Q3 2015 | $18,000 | -33.3% | 3,882 | +4.5% | 0.00% | – |
Q2 2015 | $27,000 | -95.8% | 3,714 | -95.1% | 0.00% | -100.0% |
Q1 2015 | $646,000 | -8.2% | 76,216 | +0.8% | 0.00% | 0.0% |
Q4 2014 | $704,000 | +11.9% | 75,613 | +0.1% | 0.00% | 0.0% |
Q3 2014 | $629,000 | -26.0% | 75,511 | +2.7% | 0.00% | 0.0% |
Q2 2014 | $850,000 | -2.0% | 73,523 | +7.5% | 0.00% | 0.0% |
Q1 2014 | $867,000 | +72.4% | 68,388 | +47.1% | 0.00% | 0.0% |
Q4 2013 | $503,000 | -14.9% | 46,487 | -2.7% | 0.00% | 0.0% |
Q3 2013 | $591,000 | -4.7% | 47,768 | +2.9% | 0.00% | 0.0% |
Q2 2013 | $620,000 | – | 46,422 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,161,604 | $9,676,000 | 4.16% |
DAFNA Capital Management LLC | 384,794 | $3,205,000 | 3.23% |
Consonance Capital Management LP | 1,520,404 | $12,665,000 | 1.74% |
Broadfin Capital, LLC | 1,824,377 | $15,197,000 | 1.59% |
Senvest Management, LLC | 801,445 | $6,676,000 | 0.62% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 156,261 | $1,302,000 | 0.54% |
HealthCor Management, L.P. | 920,000 | $7,664,000 | 0.39% |
ORACLE INVESTMENT MANAGEMENT INC | 326,844 | $2,723,000 | 0.38% |
Baker Brothers Advisors | 3,537,137 | $29,464,000 | 0.37% |
THB ASSET MANAGEMENT | 635,450 | $5,293,000 | 0.36% |